FrancophonIA/ELRC3.0 huggingface dataset:
English: If you accidentally take too many tablets, or if someone else or a child takes your medicine, talk to a doctor or pharmacist immediately.
Estonian: Kui te kasutate Sepioglini rohkem kui ette nähtud Informeerige oma arsti või apteekrit koheselt, kui olete kogemata võtnud liiga palju tablette või kui laps või keegi teine on võtnud teie ravimit.
English: The other ingredients are lactose monohydrate, hydroxypropylcellulose, carmellose calcium and magnesium stearate.
Estonian: - Abiained on laktoosmonohüdraat, hüdroksüpropüültselluloos, karmellooskaltsium ja magneesiumstearaat.
English: White, round, flat tablets, with “45” embossed on one side and a diameter of approximately 8.0 mm.
Estonian: Valged, ümmargused, lamedad tabletid, mille ühele küljele on pressitud „45”; tablettide läbimõõt on ligikaudu 8,0 mm.
English: INFORMATION IN BRAILLE Sepioglin 45 mg
Estonian: INFORMATSIOON BRAILLE' KIRJAS (PUNKTKIRJAS) Sepioglin 45 mg
English: Reproductive system and breast disorders erectile dysfunction General disorders and administration site conditions oedema very common fatigue uncommon
Estonian: Reproduktiivse süsteemi ja rinnanäärme häired erektsioonihäired Üldised häired ja manustamiskoha reaktsioonid tursed väga sage väsimus
English: INFORMATION IN BRAILLE Sepioglin 30 mg
Estonian: INFORMATSIOON BRAILLE' KIRJAS (PUNKTKIRJAS) Sepioglin 30 mg
English: Magnesium stearate
Estonian: artralgia seljavalu
English: 1, 28 Octovriou Str. Ag. Varvara EL-12351
Estonian: 1, 28 Octovriou str. Ag. Varvara EL-123 51 Ateena Kreeka
English: common (affects 1 to 10 users in 100) - respiratory infection - abnormal vision - weight gain - numbness uncommon (affects 1 to 10 users in 1,000) - inflammation of the sinuses (sinusitis) - difficulty sleeping (insomnia)
Estonian: sage (esineb 1-10 patsiendil 100st) - hingamisteede põletikud - nägemishäire - kehakaalu tõus - tuimus aegajalt (1-10 patsiendil 1000st) - põskkoopapõletik - unetus (insomnia)
English: Localised swelling (oedema) has also been experienced very commonly in patients taking pioglitazone in combination with insulin.
Estonian: Pioglitasooni koos insuliiniga kasutanud patsientidel on väga sageli esinenud ka lokaliseeritud paistetust (turse).
English: Blurred vision due to swelling (or fluid) at the back of the eye (frequency not known) has also been reported in patients taking pioglitazone.
Estonian: Pioglitasooni kasutavad patsiendid on teatanud ka hägusast nägemisest paistetuse (või vedeliku) tõttu silma tagaosas (sagedus pole teada).
English: One tablet of 45 mg of pioglitazone should be taken once daily.
Estonian: Võtke üks 45 mg pioglitasooni tablett üks kord ööpäevas.
English: Neoplasms benign, malignant and unspecified
Estonian: Healoomulised, pahaloomulised ja täpsustamata kasvajad (sealhulgas
English: Cardiac disorders heart failure3
Estonian: Südame häired Südamepuudulikkus3
English: PSURs
Estonian: KARP
English: The PSUR submission schedule should follow the PSUR submission schedule for the reference medicinal product.
Estonian: Ravimi perioodilise ohutusaruande (POA) tsükkel peab järgima võrdlusravimi perioodilise ohutusaruande tsüklit.
English: White, round, flat tablets, with a break line on one side, “30” embossed on the other side and a diameter of approximately 7.0 mm.
Estonian: Valged, ümmargused, lamedad tabletid, mille ühele küljele on pressitud „30”; tablettide läbimõõt on ligikaudu 7,0 mm.
English: A.
Estonian: II.
English: Your doctor will ask you to have blood tests periodically during treatment with Sepioglin.
Estonian: Võttes Sepioglini tablette, palub teie arst teil regulaarsete intervallide tagant anda vereanalüüsi.
English: Infections and infestations upper respiratory tract infection common bronchitis common sinusitis uncommon uncommon uncommon uncommon uncommon
Estonian: Infektsioonid ja infestatsioonid Ülemiste hingamisteede infektsioon bronhiit sinusiit
English: What Sepioglin looks like and contents of the pack Sepioglin 15 mg tablets are white, round, flat tablets, with “15” embossed on one side and a diameter of approximately 5.5 mm.
Estonian: Sepioglin 15 mg tabletid on valged, ümmargused, lamedad ning ühele küljele on pressitud märgistus „15”.
English: Bladder cancer has been experienced uncommonly (1 to 10 users in 1000) in patients taking pioglitazone.
Estonian: Pioglitasooni kasutanud patsientidel on aeg-ajalt (1-10 patsiendil 1000st) esinenud põievähki.
English: There may be an increased possibility of becoming pregnant because you may ovulate again when you take Sepioglin.
Estonian: Kui te võtate Sepioglini, võib teil esineda ovulatsioon, mis suurendab rasestumise võimalust.
English: Sepioglin 45 mg tablets Pioglitazone
Estonian: Sepioglin 45 mg tabletid Pioglitasoon
English: White, round, flat tablets, with “15” embossed on one side and a diameter of approximately 5.5 mm..
Estonian: Valged, ümmargused, lamedad tabletid, mille ühele küljele on pressitud märgistus „15”; tablettide läbimõõt on ligikaudu 5,5 mm.
English: One tablet of 15 mg of pioglitazone should be taken once daily.
Estonian: Võtke üks 15 mg pioglitasooni tablett üks kord ööpäevas.
English: The active substance is pioglitazone.
Estonian: Mida Sepioglin sisaldab - Sepioglini toimeaine on pioglitasoon.
English: One tablet of 30 mg of pioglitazone should be taken once daily.
Estonian: Võtke üks 30 mg pioglitasooni tablett üks kord ööpäevas.
English: Sepioglin 30 mg tablets Pioglitazone
Estonian: Sepioglin 30 mg tabletid Pioglitasoon
English: Broken bones have been reported commonly (1 to 10 users in 100) in women patients taking pioglitazone.
Estonian: Pioglitasooni kasutavad naised on sageli teatanud luumurdudest (1-10 patsiendil 100st).
English: Blood and lymphatic system disorders anaemia
Estonian: Vere ja lümfisüsteemi häired aneemia Ainevahetus- ja toitumishäired hüpoglükeemia väga sage
English: Sepioglin 15 mg tablets Pioglitazone
Estonian: Sepioglin 15 mg tabletid Pioglitasoon
English: Weight gain
Estonian: Söögiisu tõus
English: Heart failure has been experienced commonly (1 to 10 users in 100) in patients taking pioglitazone in combination with insulin.
Estonian: Sageli on pioglitasooni samal ajal insuliini kasutanud patsientidel esinenud südamepuudulikkust (1-10 patsiendil 100st).
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 45 mg pioglitazone (as hydrochloride).
Estonian: TOIMEAINE(TE) SISALDUS Iga tablett sisaldab 45 mg pioglitasooni (vesinikkloriidina)
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 30 mg pioglitazone (as hydrochloride).
Estonian: TOIMEAINE(TE) SISALDUS Iga tablett sisaldab 30 mg pioglitasooni (vesinikkloriidina)
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 30 mg of pioglitazone (as hydrochloride).
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Iga tablett sisaldab 30 mg pioglitasooni vesinikkloriidina.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 45 mg of pioglitazone (as hydrochloride).
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Iga tablett sisaldab 45 mg pioglitasooni vesinikkloriidina.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 15 mg pioglitazone (as hydrochloride).
Estonian: TOIMEAINE(TE) SISALDUS Iga tablett sisaldab 15 mg pioglitasooni (vesinikkloriidina)
English: NAME OF THE MEDICINAL PRODUCT Sepioglin 45 mg tablets
Estonian: RAVIMPREPARAADI NIMETUS Sepioglin 45 mg tabletid
English: INFORMATION IN BRAILLE Sepioglin 15 mg
Estonian: Sepioglin 15 mg
English: NAME OF THE MEDICINAL PRODUCT Sepioglin 30 mg tablets
Estonian: RAVIMPREPARAADI NIMETUS Sepioglin 30 mg tabletid
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 15 mg of pioglitazone (as hydrochloride).
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Iga tablett sisaldab 15 mg pioglitasooni vesinikkloriidina.
English: Investigations weight increased5 common common common common common blood creatine phospho-kinase increased common increased lactic dehydro-genase uncommon
Estonian: vere kreatiinfosfokinaasi tõus laktaatdehüdroge naasi aktiivsuse tõus
English: NAME OF THE MEDICINAL PRODUCT Sepioglin15 mg tablets
Estonian: RAVIMPREPARAADI NIMETUS Sepioglin 15 mg tabletid
English: What Sepioglin contains
Estonian: Kuidas Sepioglin välja näeb ja pakendi sisu
English: The tablets are supplied in PA/Aluminium/PVC/Aluminium blister packs of 14, 28, 30, 50, 56, 90 or 98tablets.
Estonian: Tabletid on 14-, 28-, 30-, 50-, 56-, 90- või 98-tabletistes PA/alumiinium/PVC/alumiiniumblisterpakendites.
English: Combination
Estonian: Imendumine
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
Estonian: B. HANKE- JA KASUTUSTINGIMUSED JA -PIIRANGUD Retseptiravim.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON
Estonian: VÄLISPAKENDIL VÕI SELLE PUUDUMISEL SISEPAKENDIL PEAVAD OLEMA JÄRGMISED ANDMED
English: EXP
Estonian: POAd
English: Gastrointestinal disorders flatulence Skin and subcutaneous tissue disorders sweating uncommon
Estonian: Naha ja nahaaluskoe kahjustused higistamine
English: NAME OF THE MEDICINAL PRODUCT Sepioglin 15 mg tablets Pioglitazone
Estonian: RAVIMPREPARAADI NIMETUS Sepioglin 15 mg tabletid Pioglitasoon
English: What Sepioglin looks like and contents of the pack Sepioglin 45 mg tablets are white, round, flat tablets, with “45” embossed on one side and a diameter of approximately 8.0 mm.
Estonian: Sepioglin 45 mg tabletid on valged, ümmargused, lamedad ning ühele küljele on pressitud märgistus „45“; tablettide läbimõõt on ligikaudu 8,0 mm. Tabletid on 14-, 28-, 30-, 50-, 56-, 90- või 98-tabletistes PA/alumiinium/PVC/alumiiniumblisterpakendites.
English: General disorders and administration site conditions oedema very common fatigue uncommon
Estonian: Üldised häired ja manustamiskoha reaktsioonid tursed väga sage väsimus
English: NAME OF THE MEDICINAL PRODUCT Sepioglin 30 mg tablets Pioglitazone
Estonian: RAVIMPREPARAADI NIMETUS Sepioglin 30 mg tabletid Pioglitasoon
English: NAME OF THE MEDICINAL PRODUCT Sepioglin 45 mg tablets Pioglitazone
Estonian: RAVIMPREPARAADI NIMETUS Sepioglin 45 mg tabletid Pioglitasoon
English: Fasting and postprandial glycaemic control is improved in patients with type 2 diabetes mellitus.
Estonian: tüüpi diabeediga patsientidel paraneb glükeemiline kontroll nii söögieelselt kui täiskõhu seisundis.
English: Four field studies were conducted.
Estonian: Tehti neli väliuuringut.
English: The tablets should be kept in the original packaging until use in order to prevent children directly accessing the medicine.
Estonian: Tablette tuleb hoida originaalpakendis kuni kasutamiseni, et takistada ravimi sattumist laste kätte.
English: Further information on Simparica Trio can be found on the Agency's website: ema.europa.eu/Find medicines/veterinary/EPAR/simparica-trio.
Estonian: Lisateave Simparica Trio kohta on ameti veebilehel: ema.europa.eu/Find medicines/veterinary/EPAR/simparica-trio.
English: The European Medicines Agency decided that Simparica Trio's benefits are greater than its risks and it can be authorised for use in the EU.
Estonian: Euroopa Ravimiamet otsustas, et Simparica Trio kasulikkus on suurem kui sellega kaasnevad riskid ja et ravimi kasutamise saab Euroopa Liidus heaks kiita.
English: Two studies conducted in Australia and one in Japan that followed a similar design to the US study also showed 100% effectiveness against naturally occurring heartworm infection.
Estonian: Kahes Austraalias ja ühes Jaapanis tehtud uuringus, mis olid kavandatud USA uuringuga sarnaselt, tõendati samuti ravimi 100% efektiivsus looduslikult leviva südameusstõve infektsiooni ravis.
English: There are no known side effects.
Estonian: Ravimil ei ole teadaolevaid kõrvalnähte.
English: Other information about Simparica Trio
Estonian: Muu teave Simparica Trio kohta
English: Simparica Trio received a marketing authorisation valid throughout the EU on 17 September 2019.
Estonian: Simparica Trio müügiluba, mis kehtib kogu Euroopa Liidus, anti 17/09/2019.
English: What is Simparica Trio and what is it used for?
Estonian: Mis on Simparica Trio ja milleks seda kasutatakse?
English: It can also be used as part of a treatment for flea allergy dermatitis (an allergic reaction to flea bites).
Estonian: Ravimit tohib kasutada ka kirbuallergiast tingitud dermatiidi (allergiline reaktsioon kirbuhammustustele) ravi osana.
English: Sarolaner acts as an ‘ectoparasiticide'.
Estonian: Sarolaneer toimib ektoparasititsiidina.
English: This results in uncontrolled activity of the nervous system and thus the paralysis and death of the parasites.
Estonian: See põhjustab parasiitide närvisüsteemi kontrollimatut talitlust ning nende paralüüsi ja surma.
English: For flea or tick infestations, one treatment with Simparica Trio is effective for up to 5 weeks.
Estonian: Kirbu- ja puugiinfestatsioonide korral kestab ühe Simparica Trio ravikuuri toime kuni 5 nädalat.
English: An overview of Simparica Trio and why it is authorised in the EU
Estonian: Simparica Trio ülevaade ja Euroopa Liidus heakskiitmise põhjused
English: Safety information has been included in the summary of product characteristics and the package leaflet for Simparica Trio, including the appropriate precautions to be followed by healthcare professionals and animal owners or keepers.
Estonian: Ravimi omaduste kokkuvõttesse ja pakendi infolehele lisati Simparica Trio ohutusteave, kus on ka tervishoiuspetsialistide ja loomaomanike või -pidajate võetavad meetmed.
English: Further flea or tick treatment should be continued using a different veterinary medicine with a narrower range of action.
Estonian: Seejärel tuleb jätkata kirbu- või puugiravi muu veterinaarravimiga, millel on kitsam toimespekter.
English: Simparica Trio (sarolaner / moxidectin / pyrantel)
Estonian: Simparica Trio (sarolaneer/moksidektiin/püranteel)
English: In a US study of 410 dogs in an area affected by heartworm disease, dogs treated with Simparica Trio every 30 days until day 300 showed 100% effectiveness based on blood tests at days 120, 240 and 330 after first treatment.
Estonian: USAs südameusstõvega piirkonnas 410 koeral tehtud uuringus oli 300 päeva jooksul iga 30 päeva järel Simparica Trioga ravitud koertel ravimi efektiivsus 100%, tuginedes 120., 240. ja 330. ravipäeval tehtud vereanalüüsidele.
English: In a field study involving 622 dogs in an area of Denmark and Italy known to be affected by lungworm disease, dogs treated with Simparica Trio every 30 days until day 270 did not test positive for lungworm until day 300 after first treatment and therefore the effectiveness was 100% with some dogs testing positive in the control group which was given a dummy treatment.
Estonian: Taanis ja Itaalias teadaolevalt kopsuusstõve levikuga piirkondades 622 koeral tehtud väliuuringus oli 270 päeva jooksul iga 30 päeva järel Simparica Trioga ravitud koerte kopsuussianalüüsi tulemus positiivne alles 300. ravipäeval ning seetõttu oli ravi efektiivsus 100% võrreldes kontrollrühmaga, kus mõned näivat ravimit saanud koerad said positiivse analüüsitulemuse.
English: Moxidectin causes paralysis and death of these parasites by interfering in a different way to sarolaner with the flow of chloride ions in nerve cells associated with GABA and glutamate.
Estonian: Moksidektiin põhjustab nende parasiitide halvatust ja surma, mõjutades sarolaneerist erineval viisil GABA ja glutamaadiga seotud kloriidiioonide liikumist närvirakkudes.
English: Simparica Trio must only be used when there is a need to treat both fleas or ticks and worms in the gut.
Estonian: Simparica Triot tohib kasutada üksnes siis, kui on vaja ravida korraga kirpe või puuke ja sooleusse.
English: For more information about using Simparica Trio, see the package leaflet or contact your veterinarian or pharmacist.
Estonian: Kui vajate ravimiga Simparica Trio toimuva ravi kohta lisateavet, lugege palun pakendi infolehte või pöörduge oma veterinaararsti või apteekri poole.
English: In areas where lungworm and heartworm are present, treatments are required at monthly intervals.
Estonian: Kopsu- ja südameusstõvega piirkondades tuleb ravi korrata iga kuu.
English: What are the risks associated with Simparica Trio?
Estonian: Mis riskid Simparica Trioga kaasnevad?
English: This means that it kills parasites present on the skin or in the fur of animals, such as fleas and ticks.
Estonian: See tähendab, et ravim hävitab parasiite, kes elavad loomade nahal või karvades, nagu kirbud või puugid.
English: This overview was last updated in July 2019.
Estonian: Kokkuvõtte viimane uuendus: 07-2019.
English: Sarolaner kills these parasites that have ingested the dog's blood by acting on their nervous system.
Estonian: Sarolaneer hävitab koera verd imenud kirbud ja puugid, mõjudes nende närvisüsteemile.
English: Roundworms and hookworms
Estonian: Ümarussid ja kidaussid
English: How does Simparica Trio work?
Estonian: Kuidas Simparica Trio toimib?
English: To prevent lungworm and heartworm disease for one month, a single treatment is required.
Estonian: Kopsu- ja südameusstõve 1-kuuliseks ennetamiseks on vaja üht ravikuuri.
English: The appropriate tablet strength should be used according to the dog's weight.
Estonian: Kasutada tuleb koera kehamassile vastava tugevusega tabletti.
English: It acts by blocking signals, normally associated with the neurotransmitter acetylcholine, from their nerves to their muscles, causing sudden contraction followed by paralysis and death.
Estonian: Püranteel blokeerib tavaliselt neurotransmitteri atsetüülkoliini poolt lihastesse edastatavaid signaale, mis põhjustab äkilisi lihasekokkutõmbeid ning seejärel halvatust ja surma.
English: Simparica Trio is available as chewable tablets and can only be obtained with a prescription.
Estonian: Simparica Trio on retseptiravim ja seda turustatakse närimistablettidena.
English: How is Simparica Trio used?
Estonian: Kuidas Simparica Triot kasutatakse?
English: In a field study in dogs infested with at least 5 live fleas, 297 dogs were treated with Simparica Trio and 164 dogs with afoxolaner and milbemycin oxime (an authorised treatment for fleas and ticks).
Estonian: Vähemalt 5 eluskirbuga nakatunud koerte väliuuringus raviti 297 koera Simparica Trioga ning 164 koera afoksolaneeri ja milbemütsiinoksiimiga (heakskiidetud kirbu- ja puugiravim).
English: Simparica Trio is a veterinary medicine used to treat dogs with flea or tick infestations and roundworm or hookworm infections in the gut.
Estonian: Simparica Trio on veterinaarravim, mida kasutatakse koertel kirbu- ja puugiinfestatsioonide ning kõhuusside (ümarussid ja kidaussid) põhjustatud sooleinfestatsioonide raviks.
English: What benefits of Simparica Trio have been shown in studies?
Estonian: Milles seisneb uuringute põhjal Simparica Trio kasulikkus?
English: It blocks the normal movement of charged chloride particles (ions) in and out of nerve cells, especially those associated with gamma-aminobutyric acid (GABA) and glutamate, two substances that convey signals between nerves (neurotransmitters).
Estonian: Toimeaine takistab eelkõige närvirakkudevahelisi signaale vahendavate neurotransmitterite gammaaminovõihappe (GABA) ja glutamaadiga seotud kloriidiioonide normaalset liikumist närvirakkudesse ja neist välja.
English: Simparica contains three active substances: sarolaner, moxidectin and pyrantel.
Estonian: Simparica Trio sisaldab kolme toimeainet: sarolaneeri, moksidektiini ja püranteeli.
English: Heartworms
Estonian: Südameussid
English: Effectiveness, based on faecal egg counts on day 7 after treatment, for dogs treated with Simparica Trio was comparable to the comparator medicine.
Estonian: Simparica Trio efektiivsus, mida mõõdeti 7. ravijärgsel päeval ravitud koerte väljaheites leitud parasiidimunade arvu põhjal, oli võrreldav võrdlusravimi efektiivsusega.
English: In a further field study in dogs infested with at least 3 live ticks, 189 dogs were treated with Simparica Trio and 91 dogs with afoxolaner and milbemycin oxime.
Estonian: Vähemalt 3 eluspuugiga nakatunud koerte lisaväliuuringus raviti 189 koera Simparica Trioga ja 91 koera afoksolaneeri ja milbemütsiinoksiimiga.
English: Moxidectin kills parasites present inside the body of animals, such as roundworms, hookworms, lungworm and heartworm.
Estonian: Moksidektiin hävitab parasiite, kes elavad looma kehas, nagu ümarussid, kidaussid, kopsuussid ja südameussid.
English: Simparica Trio contains the active substances sarolaner, moxidectin and pyrantel.
Estonian: Simparica Trio sisaldab toimeainetena sarolaneeri, moksidektiini ja püranteeli.
English: In a field study involving dogs infected with roundworms or hookworms, 194 dogs were treated with Simparica Trio and 97 dogs with afoxolaner and milbemycin oxime.
Estonian: Ümarusside või kidaussidega nakatunud koerte väliuuringus raviti 194 koera Simparica Trioga ja 97 koera afoksolaneeri ja milbemütsiinoksiimiga.
English: For gut worms only a single treatment is required.
Estonian: Sooleusside raviks piisab ühest ravikuurist.
English: The study showed Simparica Trio to be comparable to the comparator medicine as measured by the percentage reduction in live tick counts on day 7, 14, 21 and 30 after treatment.
Estonian: Uuringust selgus, et 7., 14., 21. ja 30. ravijärgsel päeval leitud eluspuukide arvu protsentuaalse vähenemise põhjal oli Simparica Trio võrreldav võrdlusravimiga.
English: The study showed Simparica Trio to be comparable to the comparator medicine as measured by flea counts on day 14 and 30 after treatment.
Estonian: Uuringus tõendati, et 14. ja 30. ravijärgsel päeval leitud kirpude arvu põhjal oli Simparica Trio võrreldav võrdlusravimiga.
English: Pyrantel also kills roundworms and hookworms present in the gut but acts differently to moxidectin.
Estonian: Püranteel hävitab sooles elavaid ümarusse ja kidausse moksidektiinist erineva toimemehhanismiga.
English: Ticks
Estonian: Puugid
English: Fleas
Estonian: Kopsuussid
English: Why is Simparica Trio authorised in the EU?
Estonian: Simparica Trio Euroopa Liidus heakskiitmise põhjused
English: At the same time, Simparica Trio is used to prevent heartworm and lungworm disease (both caused by blood worms that infect the heart and blood vessels supplying the lungs).
Estonian: Simparica Triot kasutatakse ka südame- ja kopsuusstõve ennetamiseks.
English: EPAR summary for the public telmisartan
Estonian: Kokkuvõte üldsusele telmisartaan
English: The European Commission granted a marketing authorisation valid throughout the EU for Tolura to Krka, d.d., Novo mesto on 4 June 2010.
Estonian: Euroopa Komisjon andis Tolura müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, ettevõttele Krka, d.d., Novo mesto 4. juunil 2010.
English: The Committee recommended that Tolura be given marketing authorisation.
Estonian: Komitee soovitas anda Tolura müügiloa.
English: Other information about Tolura:
Estonian: Muu teave Tolura kohta
English: The full EPAR for Tolura can be found on the Agency's website: EMA website/Find medicine/Human medicines/European Public Assessment Reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Tolura kohta on ameti veebilehel: EMA website/Find medicine/Human medicines/European Public Assessment Reports.
English: It is used in patients who have had problems due to blood clots in the past (such as heart disease or artery disease) or who have type 2 diabetes that has damaged an organ (such as the eyes, heart or kidneys).
Estonian: Ravimit kasutatakse patsientidel, kellel on olnud trombootilisi tüsistusi (nt südamehaigus, infarkt või arterite haigus) või kellel on II tüüpi diabeet (suhkurtõbi), mis on kahjustanud elundeid (nt silmi, südant või neere).
English: It also allows the heart to pump blood more easily, which can help to reduce the risk of future cardiovascular problems.
Estonian: Samuti võimaldab ravim südamel lihtsamini verd pumbata, mis aitab vähendada tulevasi kardiovaskulaarhäireid.
English: The doctor should monitor the patient's blood pressure closely when starting Tolura, and may decide to adjust the patient's blood pressure-lowering medication.
Estonian: Arst peab Tolura ravi alguses tähelepanelikult jälgima patsiendi vererõhku ning ta võib otsustada vererõhku vähendavat annust kohandada.